Faculty
Oncology Division
Alphabetical list (active faculty):   
Michael P. Rettig

Michael P. Rettig, PhD

Associate Professor

Department of Medicine

Oncology Division

Stem Cell Biology

Research Interests

  • Graft-versus-host disease
  • Hematopoietic stem cell transplantation
  • Hematopoietic stem cell mobilization

Contact

  • 314-362-9560 (office)
  • 314-362-9333 (fax)
  • Division of Oncology
    Campus Box 8007
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 636 Southwest Tower (office)
  • 634 Southwest Tower (lab)

Peer-reviewed Manuscripts

  • Combination of Dociparstat Sodium (DSTAT), a CXCL12/CXCR4 Inhibitor, With Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS
    Huselton E, Rettig MP, Campbell K, Cashen AF, DiPersio JF, Gao F, Jacoby MA, Pusic I, Romee R, Schroeder MA, Uy GL, Marcus S, Westervelt P
    Leuk Res 2021 Nov;110:106713
  • Antibody-Drug Conjugates Plus Janus Kinase Inhibitors Enable MHC-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation
    Persaud SP, Ritchey JK, Kim S, Lim S, Ruminski PG, Cooper ML, Rettig MP, Choi J, DiPersio JF
    J Clin Invest 2021 Nov 2; [Epub ahead of print]
  • 3D Tissue Engineered Plasma Cultures Support Leukemic Proliferation and Induces Drug Resistance
    Alhallak K, de la Puente P, Jeske A, Sun J, Muz B, Rettig MP, Sahin I, Weisberg EL, Griffin JD, Reagan JL, DiPersio JF, Azab AK
    Leuk Lymphoma 2021 Oct;62(10):2457-2465
  • In Vivo Quantitative Assessment of Therapeutic Response to Bortezomib Therapy in Disseminated Animal Models of Multiple Myeloma With [(18)F]FDG and [(64)Cu]Cu-LLP2A PET
    Ghai A, Fettig N, Fontana F, DiPersio J, Rettig M, O'Neal J, Achilefu S, Shoghi KI, Shokeen M
    EJNMMI Res 2021 Sep 29;11(1):97:1186
  • Machine Learning-Based Scoring Models to Predict Hematopoietic Stem Cell Mobilization in Allogeneic Donors
    Xiang J, Shi M, Fiala MA, Gao F, Rettig MP, Uy GL, Schroeder MA, Weilbaecher KN, Stockerl-Goldstein K, Mollah S, DiPersio JF
    Blood Adv 2021 Sep 23; [Epub ahead of print]
  • Functional and Epigenetic Phenotypes of Humans and Mice With DNMT3A Overgrowth Syndrome
    Smith AM, LaValle TA, Shinawi M, Ramakrishnan SM, Abel HJ, Hill CA, Kirkland NM, Rettig MP, Helton NM, Heath SE, Ferraro F, Chen DY, Adak S, Semenkovich CF, Christian DL, Martin JR, Gabel HW, Miller CA, Ley TJ
    Nat Commun 2021 Jul 27;12(1):4549
  • A Phase I Trial Evaluating the Effects of Plerixafor, G-CSF, and Azacitidine for the Treatment of Myelodysplastic Syndromes
    Huselton E, Rettig MP, Fletcher T, Ritchey J, Gehrs L, McFarland K, Christ S, Eades WC, Trinkaus K, Romee R, Kulkarni S, Ghobadi A, Abboud C, Cashen AF, Stockerl-Goldstein K, Uy GL, Vij R, Westervelt P, DiPersio JF, Schroeder MA
    Leuk Lymphoma 2021 Jun;62(6):1441-1449
  • Development of [(89)Zr]DFO-Elotuzumab for ImmunoPET Imaging of CS1 in Multiple Myeloma
    Ghai A, Zheleznyak A, Mixdorf M, O'Neal J, Ritchey J, Rettig M, DiPersio J, Shokeen M, Achilefu S
    Eur J Nucl Med Mol Imaging 2021 May;48(5):1302-1311
  • Co-Evolution of Tumor and Immune Cells During Progression of Multiple Myeloma
    Liu R, Gao Q, Foltz SM, Fowles JS, Yao L, Wang JT, Cao S, Sun H, Wendl MC, Sethuraman S, Weerasinghe A, Rettig MP, Storrs EP, Yoon CJ, Wyczalkowski MA, McMichael JF, Kohnen DR, King J, Goldsmith SR, O'Neal J, Fulton RS, Fronick CC, Ley TJ, Jayasinghe RG, Fiala MA, Oh ST, DiPersio JF, Vij R, Ding L
    Nat Commun 2021 May 7;12(1):2559
  • VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
    Fontana F, Scott MJ, Allen JS, Yang X, Cui G, Pan D, Yanaba N, Fiala MA, O'Neal J, Schmieder-Atteberry AH, Ritchey J, Rettig M, Simons K, Fletcher S, Vij R, DiPersio JF, Lanza GM
    Clin Cancer Res 2021 Apr 1;27(7):1974-1986
  • Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia
    Uy GL, Aldoss I, Foster MC, Sayre PH, Wieduwilt MJ, Advani AS, Godwin JE, Arellano ML, Sweet KL, Emadi A, Ravandi F, Erba HP, Byrne M, Michaelis L, Topp MS, Vey N, Ciceri F, Carrabba MG, Paolini S, Huls GA, Jongen-Lavrencic M, Wermke M, Chevallier P, Gyan E, Recher C, Stiff PJ, Pettit KM, Lowenberg B, Church SE, Anderson E, Vadakekolathu J, Santaguida M, Rettig MP, Muth J, Curtis T, Fehr E, Guo K, Zhao J, Bakkacha O, Jacobs K, Tran K, Kaminker P, Kostova M, Bonvini E, Walter RB, Davidson-Moncada JK, Rutella S, DiPersio JF
    Blood 2021 Feb 11;137(6):751-762
  • Biology of Disease Relapse in Myeloid Disease: Implication for Strategies to Prevent and Treat Disease Relapse After Stem-Cell Transplantation
    Rimando JC, Christopher MJ, Rettig MP, DiPersio JF
    J Clin Oncol 2021 Feb 10;39(5):386-396
  • TP53 Abnormalities Correlate With Immune Infiltration and Associate With Response to Flotetuzumab Immunotherapy in AML
    Vadakekolathu J, Lai C, Reeder S, Church SE, Hood T, Lourdusamy A, Rettig MP, Aldoss I, Advani AS, Godwin J, Wieduwilt MJ, Arellano M, Muth J, Yau TO, Ravandi F, Sweet K, Altmann H, Foulds GA, Stolzel F, Middeke JM, Ciciarello M, Curti A, Valk PJM, Lowenberg B, Gojo I, Bornhauser M, DiPersio JF, Davidson-Moncada JK, Rutella S
    Blood Adv 2020 Oct 27;4(20):5011-5024
  • Targeting CXCR4 in AML and ALL
    Cancilla D, Rettig MP, DiPersio JF
    Front Oncol 2020 Sep 4;10:1672
  • Selinexor Combined With Cladribine, Cytarabine, and Filgrastim in Relapsed or Refractory Acute Myeloid Leukemia
    Abboud R, Chendamarai E, Rettig MP, Trinkaus KM, Riedell PA, Abboud CN, Ghobadi A, Pusic I, Stockerl-Goldstein K, Schroeder MA, Vij R, Westervelt P, DiPersio JF, Uy GL
    Haematologica 2020 Aug;105(8):e404-e407
  • Immune Landscapes Predict Chemotherapy Resistance and Immunotherapy Response in Acute Myeloid Leukemia
    Vadakekolathu J, Minden MD, Hood T, Church SE, Reeder S, Altmann H, Sullivan AH, Viboch EJ, Patel T, Ibrahimova N, Warren SE, Arruda A, Liang Y, Smith TH, Foulds GA, Bailey MD, Gowen-MacDonald J, Muth J, Schmitz M, Cesano A, Pockley AG, Valk PJM, Lowenberg B, Bornhauser M, Tasian SK, Rettig MP, Davidson-Moncada JK, DiPersio JF, Rutella S
    Sci Transl Med 2020 Jun 3;12(546)
  • Interleukin-15 Superagonist (N-803) Treatment of PML and JCV in a Post-Allogeneic Hematopoietic Stem Cell Transplant Patient
    Oza A, Rettig MP, Powell P, O'Brien K, Clifford DB, Ritchey J, Gehrs L, Hollaway J, Major E, Fehniger TA, Miller CA, Soon-Shiong P, Rock A, DiPersio JF
    Blood Adv 2020 Jun 9;4(11):2387-2391
  • Mobilized Peripheral Blood: An Updated Perspective
    Karpova D, Rettig MP, DiPersio JF
    F1000Res 2019 Dec 20;8
  • A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
    Ghobadi A, Fiala MA, Rettig MP, Schroeder MA, Uy GL, Stockerl-Goldstein KE, Westervelt P, Vij R, DiPersio JF
    Clin Lymphoma Myeloma Leuk 2019 Oct;19(10):e588-e593
  • 68Ga-Galmydar: A PET Imaging Tracer for Noninvasive Detection of Doxorubicin-Induced Cardiotoxicity
    Sivapackiam J, Kabra S, Speidel S, Sharma M, Laforest R, Salter A, Rettig MP, Sharma V
    PLoS One 2019 May 23;14(5):e0215579
  • Targeting VLA4 Integrin and CXCR2 Mobilizes Serially Repopulating Hematopoietic Stem Cells
    Karpova D, Rettig MP, Ritchey J, Cancilla D, Christ S, Gehrs L, Chendamarai E, Evbuomwan MO, Holt M, Zhang J, Abou-Ezzi G, Celik H, Wiercinska E, Yang W, Gao F, Eissenberg LG, Heier RF, Arnett SD, Meyers MJ, Prinsen MJ, Griggs DW, Trumpp A, Ruminski PG, Morrow DM, Bonig HB, Link DC, DiPersio JF
    J Clin Invest 2019 May 14;130
  • CiTE Antibody for AML
    Rettig MP, DiPersio JF
    Blood 2018 Dec 6;132(23):2425-2427
  • Immune Escape of Relapsed AML Cells After Allogeneic Transplantation
    Christopher MJ, Petti AA, Rettig MP, Miller CA, Chendamarai E, Duncavage EJ, Klco JM, Helton NM, O'Laughlin M, Fronick CC, Fulton RS, Wilson RK, Wartman LD, Welch JS, Heath SE, Baty JD, Payton JE, Graubert TA, Link DC, Walter MJ, Westervelt P, Ley TJ, DiPersio JF
    N Engl J Med 2018 Dec 13;379(24):2330-2341
  • An "Off-The-Shelf" Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies
    Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF
    Leukemia 2018 Sep;32(9):1970-1983
  • Preclinical Development of a Bispecific Antibody That Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia
    Buatois V, Johnson Z, Salgado-Pires S, Papaioannou A, Hatterer E, Chauchet X, Richard F, Barba L, Daubeuf B, Cons L, Broyer L, D'Asaro M, Matthes T, LeGallou S, Fest T, Tarte K, Clarke Hinojosa RK, Genesca Ferrer E, Ribera JM, Dey A, Bailey K, Fielding AK, Eissenberg L, Ritchey J, Rettig M, DiPersio JF, Kosco-Vilbois MH, Masternak K, Fischer N, Shang L, Ferlin WG
    Mol Cancer Ther 2018 Aug;17(8):1739-1751
  • Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome
    Rettig MP
    Biol Blood Marrow Transplant 2018 Jul;24(7):1309-1311
  • Ixazomib, an Oral Proteasome Inhibitor, Induces Rapid Mobilization of Hematopoietic Progenitor Cells in Mice
    Ghobadi A, Rettig MP, Holt MS, Ritchey JK, Kennerly K, Chendamarai E, Eissenberg L, DiPersio JF
    Blood 2018 Jun 7;131(23):2594-2596
  • Preclinical Development of CD38-Targeted [(89)Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma
    Ghai A, Maji D, Cho N, Chanswangphuwana C, Rettig M, Shen D, DiPersio J, Akers W, Dehdashti F, Achilefu S, Vij R, Shokeen M
    J Nucl Med 2018 Feb;59(2):216-222
  • Radionuclides Transform Chemotherapeutics Into Phototherapeutics for Precise Treatment of Disseminated Cancer
    Kotagiri N, Cooper ML, Rettig M, Egbulefu C, Prior J, Cui G, Karmakar P, Zhou M, Yang X, Sudlow G, Marsala L, Chanswangphuwana C, Lu L, Habimana-Griffin L, Shokeen M, Xu X, Weilbaecher K, Tomasson M, Lanza G, DiPersio JF, Achilefu S
    Nat Commun 2018 Jan 18;9(1):275
  • Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony-Stimulating Factor in Lymphoma Patients Undergoing Autologous Stem Cell Collection
    Cashen AF, Rettig M, Gao F, Smith A, Abboud C, Stockerl-Goldstein K, Vij R, Uy G, Westervelt P, DiPersio J
    Biol Blood Marrow Transplant 2017 Aug;23(8):1282-1289
  • Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia
    Han L, Jorgensen JL, Brooks C, Shi C, Zhang Q, Nogueras Gonzalez GM, Cavazos A, Pan R, Mu H, Wang SA, Zhou J, Ai-Atrash G, Ciurea SO, Rettig M, DiPersio JF, Cortes J, Huang X, Kantarjian HM, Andreeff M, Ravandi F, Konopleva M
    Clin Cancer Res 2017 Jul 1;23(13):3385-3395
  • Continuous Blockade of CXCR4 Results in Dramatic Mobilization and Expansion of Hematopoietic Stem and Progenitor Cells
    Karpova D, Ritchey JK, Holt MS, Abou-Ezzi G, Monlish D, Batoon L, Millard S, Spohn G, Wiercinska E, Chendamarai E, Yang W, Christ S, Gehrs L, Schuettpelz LG, Dembowsky K, Pettit AR, Rettig MP, Bonig H, DiPersio JF
    Blood 2017 May 25;129(21):2939-2949
  • Mobilization of Allogeneic Peripheral Blood Stem Cell Donors With Intravenous Plerixafor Mobilizes a Unique Graft
    Schroeder MA, Rettig MP, Lopez S, Christ S, Fiala M, Eades W, Mir FA, Shao J, McFarland K, Trinkaus K, Shannon W, Deych E, Yu J, Vij R, Stockerl-Goldstein K, Cashen AF, Uy GL, Abboud CN, Westervelt P, DiPersio JF
    Blood 2017 May 11;129(19):2680-2692
  • A Phase 1/2 Study of Chemosensitization With Plerixafor Plus G-CSF in Relapsed or Refractory Acute Myeloid Leukemia
    Uy GL, Rettig MP, Stone RM, Konopleva MY, Andreeff M, McFarland K, Shannon W, Fletcher TR, Reineck T, Eades W, Stockerl-Goldstein K, Abboud CN, Jacoby MA, Westervelt P, DiPersio JF
    Blood Cancer J 2017 Mar 10;7(3):e542
  • Enhanced in Utero Allogeneic Engraftment in Mice After Mobilizing Fetal HSCs by Alpha4beta1/7 Inhibition
    Kim AG, Vrecenak JD, Boelig MM, Eissenberg L, Rettig MP, Riley JS, Holt MS, Conner MA, Loukogeorgakis SP, Li H, DiPersio JF, Flake AW, Peranteau WH
    Blood 2016 Nov 17;128(20):2457-2461
  • Severe Cytokine-Release Syndrome After T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated With Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated
    Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2016 Oct;22(10):1851-60
  • Gold Nanoclusters Doped With 64Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis
    Zhao Y, Detering L, Sultan D, Cooper ML, You M, Cho S, Meier SL, Luehmann H, Sun G, Rettig M, Dehdashti F, Wooley KL, DiPersio JF, Liu Y
    ACS Nano 2016 Jun 28;10(6):5959-5970
  • Phase-1/-2 Study of Pomalidomide in Chronic GvHD
    Pusic I, Rettig MP, DiPersio JF, Bauer S, McFarland K, Gale RP, Pavletic SZ
    Bone Marrow Transplant 2016 Apr;51(4):612-614
  • Ex Vivo and in Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
    Soodgupta D, Zhou H, Beaino W, Lu L, Rettig M, Snee M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Anderson CJ, Tomasson MH, Shokeen M
    J Nucl Med 2016 Apr;57(4):640-5
  • Targeting CD123 in Acute Myeloid Leukemia Using a T-Cell-Directed Dual-Affinity Retargeting Platform
    Al-Hussaini M, Rettig MP, Ritchey JK, Karpova D, Uy GL, Eissenberg LG, Gao F, Eades WC, Bonvini E, Chichili GR, Moore PA, Johnson S, Collins L, DiPersio JF
    Blood 2016 Jan 7;127(1):122-31
  • [(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility
    Eissenberg LG, Rettig MP, Ritchey JK, Prior JL, Schwarz SW, Frye J, White BS, Fulton RS, Ghobadi A, Cooper ML, Couriel DR, Seegulam ME, Piwnica-Worms D, Dehdashti F, Cornetta K, DiPersio JF
    Mol Ther 2015 Jun;23(6):1110-22
  • Sphingosine-1-Phosphate Facilitates Trafficking of Hematopoietic Stem Cells and Their Mobilization by CXCR4 Antagonists in Mice
    Juarez JG, Harun N, Thien M, Welschinger R, Baraz R, Dela Pena A, Pitson SM, Rettig M, DiPersio JF, Bradstock KF, Bendall LJ
    Blood 2012 Jan 19;119(3):707-16
  • Preclinical Evaluation of Mab CC188 for Ovarian Cancer Imaging
    Xu M, Rettig MP, Sudlow G, Wang B, Akers WJ, Cao D, Mutch DG, DiPersio JF, Achilefu S
    Int J Cancer 2012 Sep 15;131(6):1351-9
  • Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells From Cytarabine Induced Apoptosis
    Macanas-Pirard P, Leisewitz A, Broekhuizen R, Cautivo K, Barriga FM, Leisewitz F, Gidi V, Riquelme E, Montecinos VP, Swett P, Besa P, Ramirez P, Ocqueteau M, Kalergis AM, Holt M, Rettig M, DiPersio JF, Nervi B
    PLoS One 2012;7(5):e37203
  • A Phase 1/2 Study of Chemosensitization With the CXCR4 Antagonist Plerixafor in Relapsed or Refractory Acute Myeloid Leukemia
    Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF
    Blood 2012 Apr 26;119(17):3917-24
  • BIO5192, a Small Molecule Inhibitor of VLA-4, Mobilizes Hematopoietic Stem and Progenitor Cells
    Ramirez P, Rettig MP, Uy GL, Deych E, Holt MS, Ritchey JK, DiPersio JF
    Blood 2009 Aug 13;114(7):1340-3
  • Chemosensitization of Acute Myeloid Leukemia (AML) Following Mobilization by the CXCR4 Antagonist AMD3100
    Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK, Prior JL, Piwnica-Worms D, Bridger G, Ley TJ, DiPersio JF
    Blood 2009 Jun 11;113(24):6206-14
  • Rapid Mobilization of Functional Donor Hematopoietic Cells Without G-CSF Using Plerixafor, an Antagonist of the CXCR4/SDF-1 Interaction
    Devine SM, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N, Devine H, Link DC, Calandra G, Bridger G, Westervelt P, DiPersio JF
    Blood 2008 Aug 15;112(4):990-8
  • Factors Affecting Human T Cell Engraftment, Trafficking, and Associated Xenogeneic Graft-Vs-Host Disease in NOD/SCID Beta2mnull Mice
    Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF
    Exp Hematol 2007 Dec;35(12):1823-38
  • Erythrocyte Adhesion Is Modified by Alterations in Cellular Tonicity and Volume
    Wandersee NJ, Punzalan RC, Rettig MP, Kennedy MD, Pajewski NM, Sabina RL, Paul Scott J, Low PS, Hillery CA
    Br J Haematol 2005 Nov;131(3):366-77
  • Kinetics of in Vivo Elimination of Suicide Gene-Expressing T Cells Affects Engraftment, Graft-Versus-Host Disease, and Graft-Versus-Leukemia After Allogeneic Bone Marrow Transplantation
    Rettig MP, Ritchey JK, Prior JL, Haug JS, Piwnica-Worms D, DiPersio JF
    J Immunol 2004 Sep 15;173(6):3620-30
  • Transduction and Selection of Human T Cells With Novel CD34/Thymidine Kinase Chimeric Suicide Genes for the Treatment of Graft-Versus-Host Disease
    Rettig MP, Ritchey JK, Meyerrose TE, Haug JS, DiPersio JF
    Mol Ther 2003 Jul;8(1):29-41
  • Altered Erythrocyte Endothelial Adherence and Membrane Phospholipid Asymmetry in Hereditary Hydrocytosis
    Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS
    Blood 2003 Jun 1;101(11):4625-7
  • Protein Kinase C Activation Induces Phosphatidylserine Exposure on Red Blood Cells
    de Jong K, Rettig MP, Low PS, Kuypers FA
    Biochemistry 2002 Oct 15;41(41):12562-7
  • Effect of PH on the Self-Association of Erythrocyte Band 3 in Situ
    Rettig MP, Orendorff CJ, Campanella E, Low PS
    Biochim Biophys Acta 2001 Nov 1;1515(1):72-81
  • Evaluation of Biochemical Changes During in Vivo Erythrocyte Senescence in the Dog
    Rettig MP, Low PS, Gimm JA, Mohandas N, Wang J, Christian JA
    Blood 1999 Jan 1;93(1):376-84
  • How Old Are Dense Red Blood Cells? The Dog's Tale
    Christian JA, Wang J, Kiyatkina N, Rettig M, Low PS
    Blood 1998 Oct 1;92(7):2590-1
  • Evaluation of Canines for Accelerant Detection at Fire Scenes
    Kurz ME, Billard M, Rettig M, Augustiniak J, Lange J, Larsen M, Warrick R, Mohns T, Bora R, Broadus K
    J Forensic Sci 1994 Nov;39(6):1528-36

Invited Reviews and Chapters

  • Marrow Microenvironment and Biology of Mobilization of Stem Cells
    Rettig MP, Schroeder M, DiPersio JF
    In: Thomas' Hematopoietic Cell Transplantation, 2014
  • Mobilization of Hematopoietic Stem and Progenitor Cells Using Inhibitors of CXCR4 and VLA-4
    Rettig MP, Ansstas G, DiPersio JF
    Leukemia 2012 Jan;26(1):34-53
  • Chapter 2 CXCR4 and Mobilization of Hematopoietic Precursors
    Rettig MP, Ramirez P, Nervi B, DiPersio JF
    Methods Enzymol 2009;460:57-90
  • Plerixafor, a CXCR4 Antagonist for the Mobilization of Hematopoietic Stem Cells
    Uy GL, Rettig MP, Cashen AF
    Expert Opin Biol Ther 2008 Nov;8(11):1797-804
  • Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation
    Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF
    Biol Blood Marrow Transplant 2008 Sep;14(9):1045-56